Search Results

Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Caron on the web UNC-Chapel Hill Department of Cell Biology and Physiology UNC Lineberger Comprehensive Cancer In addition to research, Dr. Program and is working to build relationships with key stakeholders through institutional and community

was focused on investigating the cellular effects of missense lung cancer-mutations in the G-protein-coupled Sciences, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA 5 O'Neal Comprehensive Cancer Van Meir pursued postdoctoral work at the Ludwig Institute for Cancer Research in San Diego and joined novel medicines for cancer treatment." Velia Fowler, at the Scripps Research Institute, as a Judith Graham Poole postdoctoral fellow to work

Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons ), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009, appointed Professor of Pharmacology at Macquarie University. Mark Connor on the web Researchers Twitter Google Scholar Dr. GPCR Ecosystem Enjoying the Dr.

of Medicine, where he studies BAI1's role in the brain and the radiobiology of treatments for brain cancer , UK 2Proteomics Science Technology Platform, The Francis Crick Institute, UK" About Simeon R. Mihaylov " I am a postdoctoral researcher in the kinases and brain development laboratory led by Dr Sila Ultanir at the Francis Crick Institute in London, England. Anne Bormann on the web Rudolf-Schönheimer-Institut für Biochemie Scholz Lab < Previous Session Next

in vitro Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute Research interests: Signaling mechanisms involving GPCRs and heterotrimeric G proteins" Dr. Evi Kostenis on the web University of Bonn ResearchGate LinkedIn Dr. GPCR Enjoying the Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Stéphane Laporte is a Professor of Medicine, and the Director of Research of the Division of Endocrinology Institute of the McGill University Health Centre (RI-MUHC). He has received many awards, including a Canada Research Chair, FRSQ scholarships and the CDA/CSEM/Merck His expertise is in molecular pharmacology and his research program focuses on the molecular and cellular The Canadian Institutes for Health Research and March of Dimes currently support his research."

Catherine Demery shares how she found clarity and purpose in academic opioid research. building translational experiments, and using real-world data to drive impactful science in the GPCR research Her research combines cutting-edge GPCR signaling studies with real-time public health data from Michigan The role of public health programs in informing lab research. Her next stop: the NIH, studying the immunology of pregnancy.

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of His research career has focused on the investigation of the regulation of G protein-coupled receptors He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr

Arun Shukla from the Indian Institute of Technology in Kanpur, India. Arun first started working on GPCRs and their structural characterization at the Max Planck Institute Shukla’s research and how working in the lab instead of going to classes made him realize that research Arun Shukla on the web Indian Institute of Technology Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Since then, Brendan worked as a research assistant at the Victor Chang Cardiac Research Institute where post-doctoral positions to begin in mid-2024" Brendan Wilkins on the web UNSW Sydney Google Scholar ResearchGate How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Alexander is currently a postdoc as a member of the personalized medicine cluster in Copenhagen and at the Institute Alexander had a research sabbatical with Madan Babu at the MRC Laboratory of Molecular Biology in Cambridge He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D. Hauser on the web Twitter ResearchGate University of Copenhagen LinkedIn Google Scholar Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

The research group led by Dr. located in the Centro de Biología Molecular “Severo Ochoa” (UAM/CSIC) and belongs also to the Health Research Institute La Princesa, has extensive experience in the field of GPCR. (GRK2), a known regulator of Gq-GPCR signaling in HNSCC tumor progression (International Journal of Cancer

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of His research career has focused on the investigation of the regulation of G protein-coupled receptors He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr

Antonella Di Pizio, an independent research group leader at the Leibniz Institute for Food Systems Biology Today, Antonella has expanded her research to olfactory GPCRs and trace amine receptors. Antonella Di Pizio on the web Leibniz-Institute for Food Systems Biology at the Technical University How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors Shivani Sachdev on the web NIDDK ReseachGate Google Scholar LinkedIn Twitter Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

UK, Wellcome Trust, and the Medical Research Council. Caroline Gorvin is a Wellcome Trust & Royal Society Sir Henry Dale Fellow at the Institute of Metabolism and Systems Research, University of Birmingham. Caroline moved to the University of Birmingham in 2018 to establish her research group investigating Her current research focuses on how metabolic GPCRs cross-talk and interact to regulate appetite and

He then earned his Ph.D. in physical chemistry from the Massachusetts Institute of Technology, training GPCRs while training in the laboratories of Professors Raymond Stevens and Kurt Wüthrich at The Scripps Research Institute. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin Lohse at the Institute After my Ph.D. defense in 2019, I moved with a DFG (German research council) PostDoc fellowship to Stockholm , Sweden, in order to focus my research on class Frizzled GPCR s in the lab of Gunnar Schulte at the Karolinska Institute. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

The overall goal of her research program is to obtain rigorous mechanistic insights into the structure at the Second University of Naples and a postdoctorate in Computational Biophysics at the Molecular Research Institute in California, USA. Filizola on the web Icahn School of Medicine at Mount Sinai Filizola Lab Wikipedia Twitter Linkedin ResearchGate How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

discovery… I was in love with the topic.” – Alessandro Nicoli Working on docking and NMR studies for cancer-related From Researcher to Mentor: Growing Together Outside his research, Nicoli mentors students, manages interns Keyword Cloud GPCR research community , Dr. Antonella Di Pizio at the Leibniz Institute for Food Systems Biology at the Technical University of Munich Alessandro Nicoli on the web Leibniz Institute for Food Systems Biology at the Technical University of

How an integrated training and lab structure at Monash Institute of Pharmaceutical Sciences fosters innovation in functional assay development and GPCR research. ⸻ Why It Might Hit Home If you’ve ever: Faced unexpected Associate Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute She established her lab in 2011, and today she is a Viertel Senior Medical Research Fellow. Leader Award. ⸻ More about Michelle Halls Monash Institute of Pharmaceutical Sciences Bluesky LinkedIn

While a chemistry undergraduate student at the University of Chicago, he attended a NATO Advanced Study Institute After moving to Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced and Ping Chi , that a mutant of CYSLTR2 is a driver oncogene in uveal melanoma, the most common eye cancer Sakmar on the web LinkedIn ResearchGate Pubmed ORCHID Google Scholar Rockefeller University Wikipedia How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes Yamina Berchiche on the web Website LinkedIn Facebook Twitter ResearchGate PubMed Google Scholar Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

training as a postdoctoral fellow at the Vanderbilt Center for Neuroscience Drug Discovery, the National Institute of General Medical Sciences, and the National Institute on Alcohol Abuse and Alcoholism. Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Davide Calebiro "Davide Calebiro is Chair of Molecular Endocrinology and Wellcome Trust Senior Research Fellow at the Institute of Metabolism and Systems Research (IMSR) of the University of Birmingham and Between 2009 and 2017, he was a Group Leader at the Institute of Pharmacology and Toxicology and Rudolf He leads a multidisciplinary research team comprising biologists, chemists, physicists, engineers and How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

After obtaining a Postdoctoral Fellowship from the Canadian Institutes of Health Research in 2012, Bianca joined the research group of Prof Michel Bouvier at Université de Montréal. In 2018, Bianca was appointed Vice-Chancellor’s Fellow at Queen’s University Belfast to develop her research Bianca Plouffe on the web Queen's University Belfast website LinkedIn ResearchGate ORCID Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Gloriam is a Professor in Computational Receptor Biology at the University of Copenhagen where he leads a research His group runs the GPCRdb database where ~4,000 researchers each month retrieve reference data and access He completed two postdocs in the UK at the EMBL-European Bioinformatics Institute and GlaxoSmithKline Gloriam on the web LinkedIn ResearchGate Twitter Google Scholar Computation Receptor Biology- Gloriam How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

His postdoctoral training included research at the École Polytechnique Fédérale de Lausanne (2015–2016 ) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both postdoc Since 2020, JB has led his research group at the Leibniz Research Institute for Molecular Pharmacology Johannes Broichhagen on the Web LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular

In this institution dear to the heart of GPCR enthusiasts given that its faculty personnel included Dr integrating the department of Cell Biology at the Centro de Investigación y de Estudios Avanzados del Instituto He also actively volunteers as an Associate Professor of the non-governmental organization Institut des Boucard Jr. on the web Website LinkedIn Researchgate Loop Academia Pubmed Adhesion GPCR Consortium University How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the University of Montreal in Canada before training at The Rockefeller University in New York and the National Institutes Yamina Berchiche on the web Website LinkedIn Facebook Twitter ResearchGate PubMed Google Scholar Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research